NL-OMON21837招募中不适用
engthening Adalimumab Dosing Interval in quiescent Crohn’s disease patients
Radboud university medical center, PO box 9101, 6500 HB Nijmegen Geert-Grooteplein Zuid 100 个研究点目标入组 174 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 174
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- • Age 18 or older
- • Diagnosis of colonic and/or distal ileal CD
排除标准
- • Absence of written informed consent
- • Concomitant corticosteroid usage
研究者
相似试验
招募中
4 期
engthening Adalimumab Dosing Interval in quiescent Crohn*s disease patients: the LADI study.Crohn's diseaseNL-OMON47881Radboud Universitair Medisch Centrum174
进行中（未招募）
1 期
Stepwise extention of the adalimumab injection interval in patients with stable Crohn's disease.Crohn's diseaseEUCTR2016-003321-42-NLRadboud University Medical Centre
招募中
不适用
Increasing time between adalimumab injections in IBD patients.Crohn's DiseaseUlcerative ColitisInflammatory Bowel DiseaseAdalimumabNL-OMON20310Erasmus MC72
尚未招募
4 期
engthening Adalimumab Dosing Interval in IBD patients in long term remission, the LADI study.Inflammatory bowel disease10017969NL-OMON40962Erasmus MC, Universitair Medisch Centrum Rotterdam80
进行中（未招募）
不适用
Increasing the time between adalimumab injections from two to threeweeks, in patients with inflammatory bowel disease.Inflammatory bowel diseaseEUCTR2014-001919-39-NLErasmus MC